1. LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells
   Huajun Wu et al, 2020, Cancer Cell International CrossRef
2. Kupffer cells and liver
   Muhammad Jahangir Hossen et al, 2022, Recent Advancements in Microbial Diversity CrossRef
3. FCGR3A Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lower-Grade Glioma
   Kai Sun et al, 2022, Journal of Oncology CrossRef
4. Research Progress on Immune Function of Kupffer Cells
   朝兴 廖, 2021, Advances in Clinical Medicine CrossRef
5. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives
   Janitha M. Unagolla et al, 2024, International Journal of Pharmaceutics CrossRef
6. Clinical Data on Immunotherapy in Breast Cancer
   Julia Caroline Radosa et al, 2020, Breast Care CrossRef
7. Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression
   Qi Zhang et al, 2018, World Journal of Gastroenterology CrossRef
8. The Biological Function of Kupffer Cells in Liver Disease
   Yuan-yuan Ma et al, 2017, Biology of Myelomonocytic Cells CrossRef
9. Discovery of highly immunogenic spleen-resident FCGR3+CD103+ cDC1s differentiated by IL-33-primed ST2+ basophils
   Myeong-Ho Kang et al, 2023, Cellular & Molecular Immunology CrossRef
10. Agalactosyl IgG induces liver fibrogenesis via Fc gamma receptor 3a on human hepatic stellate cells
    Cheng‐Hsun Ho et al, 2024, The Journal of Pathology CrossRef